QA: Ocata Therapeutics Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001140098_2014_Ocata_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning NetIncome node detected by IncomeLoss name heuristic input.sec.calculation_linkbase.edgar_model_mapping {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001140098, Ocata Therapeutics Inc

  xvar xval
0 AssetsCurrent 2,911,859
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 753,576
3 remainder_Assets 242,484
4 LiabilitiesCurrent 22,916,789
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,524,740
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,057,067
9 ResearchAndDevelopmentExpense 11,564,768
10 remainder_Expenses 6,228,621
11 remainder_Revenues 0
12 remainder_NetIncome -1,171,792
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,907,919
1 Liabilities 26,441,529
2 Expenses 29,850,456
3 Revenues 0
4 StockholdersEquity -22,533,610
5 NetIncome -31,022,248
6 ComprehensiveNetIncome -31,022,248
7 BaseVar 30,685,848
8 EconomicCapitalRatiobeforeLimitedLiability -5.28
9 EconomicCapitalRatio 0.151

Edgar->Model Mapping

Feature Distribution

Change over Time